As of 9:23:39 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TG40.F | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
UKJ2.DU Opthea Ltd. R
3.1000
+2.65%
UKJ.F Opthea Limited
0.4020
+4.15%
TF2.DU Takara Bio Inc
5.90
+2.61%
TPM0.F Tonix Pharmaceuticals Holding Corp.
0.0000
-100.00%
TRGNF Transgene SA
1.5900
0.00%
TKBIF
23.20
0.00%
TCF.L Theracryf Plc
0.5350
+1.90%
TNG.PA Transgene SA
0.7000
-0.28%
UBM.MI Ulisse Biomed S.p.A.
0.7940
+2.58%
THER Theralink Technologies, Inc.
0.0001
0.00%